News

23.09.2024

Presenting Key Insights from the IMSS Survey at ECTRIMS 2024

We are excited to share that the European Multiple Sclerosis Platform (EMSP) has presented the preliminary findings from the Impact…

Engaging Expert Patients: MS CAB and EBV-MS Project Team Collaborate on Clinical Trial Design

12.07.2024

On June 19, 2024, the Multiple Sclerosis Community Advisory Board (MS CAB) met with the EBV-MS project research team for…

Preliminary Results of the Impact of Multiple Sclerosis Symptoms (IMSS) Survey Presented at RIMS Annual Conference

09.07.2024

The 29th annual RIMS Conference held between 27 and 29 June 2024, marked a significant milestone for the MS community…

27.07.2023

EMSP Annual Conference 2023 – Social Policy: A Better Life for People with MS

People came from the warm shores of the Mediterranean, the colder climes of the Atlantic coast and central Europe… it…

EMSP @ ECTRIMS 2022 – Key takeaways

30.11.2022

ECTRIMS is the world’s largest annual international conference devoted to basic and clinical research and care in multiple sclerosis. The…

ECTRIMS 2021 – Day 3 Keep us moving – from Patient Perspectives to Rehabilitation

18.10.2021

The themes of ECTRIMS Day 3 gave the audience a perspective and a view into the future. Discussed topics included…

15.10.2021

ECTRIMS 2021 – Day 2 The Digital Experience Goes into the Next Round!

The themes of ECTRIMS Day 2 were spinning around Disease-Modifying Treatments (DMTs) addressing the question if and when to stop,…

ECTRIMS 2021 Day 1 – The Digital Experience in Multiple Sclerosis has started

14.10.2021

This years’ ECTRIMS Congress – the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis –…

#EMSPVirtual2021: Keynote Speech of MEP Katarina Konecna

29.09.2021

In her keynote speech MEP Katerîna Konečna addressed the need for protection and involvement of caregivers and patients, using the…

1 2